Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,128,365
-
Share change
-
+2,337,313
-
Total reported value
-
$152,227,185
-
Price per share
-
$15.03
-
Number of holders
-
40
-
Value change
-
+$35,243,284
-
Number of buys
-
30
-
Number of sells
-
9
Institutional Holders of TCR2 THERAPEUTICS INC - COM (TCRR) as of Q3 2019
As of 30 Sep 2019,
TCR2 THERAPEUTICS INC - COM (TCRR) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,128,365 shares.
The largest 10 holders included
MPM ASSET MANAGEMENT LLC, Redmile Group, LLC, ArrowMark Colorado Holdings LLC, BlackRock Inc., Artal Group S.A., VANGUARD GROUP INC, HILLHOUSE CAPITAL ADVISORS, LTD., JPMORGAN CHASE & CO, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.